review article | Q7318358 |
scholarly article | Q13442814 |
P356 | DOI | 10.1111/J.1463-1326.2006.00620.X |
P8608 | Fatcat ID | release_cflxpb7s3bglrda6wbdtoq4jqa |
P698 | PubMed publication ID | 17587387 |
P2093 | author name string | Jane E-B Reusch | |
Boris B Draznin | |||
P2860 | cites work | Roles for insulin receptor, PI3-kinase, and Akt in insulin-signaling pathways related to production of nitric oxide in human vascular endothelial cells | Q22253424 |
The L-arginine-nitric oxide pathway | Q24304874 | ||
Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study | Q24652963 | ||
Hyperglycemia-induced mitochondrial superoxide overproduction activates the hexosamine pathway and induces plasminogen activator inhibitor-1 expression by increasing Sp1 glycosylation | Q24682735 | ||
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group | Q27860882 | ||
Matrix metalloproteinases in early diabetic retinopathy and their role in alteration of the blood-retinal barrier | Q28235057 | ||
High-glucose-induced structural changes in the heparan sulfate proteoglycan, perlecan, of cultured human aortic endothelial cells | Q28253845 | ||
Inflammation, atherosclerosis, and coronary artery disease | Q29547232 | ||
Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey | Q29614468 | ||
The pathobiology of diabetic complications: a unifying mechanism | Q29617766 | ||
Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction | Q29618673 | ||
Hyperglycaemia-induced superoxide production decreases eNOS expression via AP-1 activation in aortic endothelial cells | Q30434846 | ||
Tight glycemic control in diabetic coronary artery bypass graft patients improves perioperative outcomes and decreases recurrent ischemic events. | Q30759070 | ||
Vascular endothelial growth factor expression of intercellular adhesion molecule 1 (ICAM-1), vascular cell adhesion molecule 1 (VCAM-1), and E-selectin through nuclear factor-kappa B activation in endothelial cells | Q31660362 | ||
PPAR-alpha and PPAR-gamma activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway | Q31793810 | ||
Mechanisms underlying endothelial dysfunction in diabetes mellitus | Q31829307 | ||
Overexpression of human heme oxygenase-1 attenuates endothelial cell sloughing in experimental diabetes | Q45000328 | ||
Effect of pioglitazone on carotid intima-media thickness and arterial stiffness in type 2 diabetic nephropathy patients | Q45064729 | ||
Preventative effects of rosiglitazone on restenosis after coronary stent implantation in patients with type 2 diabetes. | Q45124478 | ||
Hyperlipidemia in concert with hyperglycemia stimulates the proliferation of macrophages in atherosclerotic lesions: potential role of glucose-oxidized LDL. | Q45161321 | ||
Exercise reduces preexisting atherosclerotic lesions in LDL receptor knock out mice | Q45177977 | ||
High glucose inhibits apoptosis induced by serum deprivation in vascular smooth muscle cells via upregulation of Bcl-2 and Bcl-xl | Q45242127 | ||
Expression levels and functional aspects of the hyaluronan receptor CD44. Effects of insulin, glucose, IGF-I, or growth hormone on human arterial smooth muscle cells | Q45286381 | ||
Exercise might favor reverse cholesterol transport and lipoprotein clearance: potential mechanism for its anti-atherosclerotic effects | Q46429833 | ||
At least 2 distinct pathways generating reactive oxygen species mediate vascular cell adhesion molecule-1 induction by advanced glycation end products | Q46450292 | ||
Glucose-induced up-regulation of CD36 mediates oxidative stress and microvascular endothelial cell dysfunction. | Q46509014 | ||
RAGE modulates vascular inflammation and atherosclerosis in a murine model of type 2 diabetes | Q46631889 | ||
Insulin action enhancement normalizes brachial artery vasoactivity in patients with peripheral vascular disease and occult diabetes. | Q51566310 | ||
Relationship of walking to mortality among US adults with diabetes. | Q51666294 | ||
Regulation of endothelial constitutive nitric oxide synthase gene expression in endothelial cells and in vivo : a specific vascular action of insulin. | Q54062879 | ||
Associations of coronary heart disease risk factors with the intermediate lesion of atherosclerosis in youth. The Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group. | Q55034145 | ||
High glucose induces human endothelial cell apoptosis through a phosphoinositide 3-kinase-regulated cyclooxygenase-2 pathway. | Q33210941 | ||
Cellular mechanisms of insulin resistance in humans | Q33694764 | ||
Insulin signaling in the arterial wall | Q33694779 | ||
Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS: 23) | Q33764951 | ||
Recent advances in our understanding of insulin action and insulin resistance | Q34209698 | ||
Glycation, inflammation, and RAGE: a scaffold for the macrovascular complications of diabetes and beyond | Q34282992 | ||
Identification of AF-6 and canoe as putative targets for Ras. | Q34371134 | ||
Diabetes and atherosclerosis: epidemiology, pathophysiology, and management | Q34646074 | ||
Hyperglycemia alters PI3k and Akt signaling and leads to endothelial cell proliferative dysfunction | Q35103906 | ||
Monocyte chemoattractant protein 1 in obesity and insulin resistance | Q35163496 | ||
The potential role of peroxisome proliferator-activated receptors on inflammation in type 2 diabetes mellitus and atherosclerosis | Q35212555 | ||
Molecular mechanisms of insulin resistance that impact cardiovascular biology | Q35927757 | ||
The effect of exercise training on endothelial function in cardiovascular disease in humans | Q35987165 | ||
Inhibition of GAPDH activity by poly(ADP-ribose) polymerase activates three major pathways of hyperglycemic damage in endothelial cells | Q36001244 | ||
Proatherosclerotic mechanisms involving protein kinase C in diabetes and insulin resistance | Q36002036 | ||
Rho-kinase mediates hyperglycemia-induced plasminogen activator inhibitor-1 expression in vascular endothelial cells | Q37079170 | ||
Intensive diabetes therapy and carotid intima-media thickness in type 1 diabetes mellitus | Q37239783 | ||
Diabetes and diabetes-associated lipid abnormalities have distinct effects on initiation and progression of atherosclerotic lesions | Q37486465 | ||
Metformin prevents high-glucose-induced endothelial cell death through a mitochondrial permeability transition-dependent process | Q40404137 | ||
Insulin regulation of sterol regulatory element-binding protein-1 expression in L-6 muscle cells and 3T3 L1 adipocytes | Q40547543 | ||
Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts | Q41009444 | ||
Advanced glycation end products, oxidant stress and vascular lesions | Q41375234 | ||
Hyperglycemia enhances angiotensin II-induced janus-activated kinase/STAT signaling in vascular smooth muscle cells | Q42479400 | ||
Pathological roles of advanced glycation end product receptors SR-A and CD36. | Q42812060 | ||
Scavenger receptor class B type I-mediated reverse cholesterol transport is inhibited by advanced glycation end products | Q43560094 | ||
Diabetes accelerates smooth muscle accumulation in lesions of atherosclerosis: lack of direct growth-promoting effects of high glucose levels | Q43566166 | ||
Glucose-induced hyperproliferation of cultured rat aortic smooth muscle cells through polyol pathway hyperactivity | Q43611292 | ||
Rapid communication: inhibitory effect of pioglitazone on carotid arterial wall thickness in type 2 diabetes | Q43666606 | ||
The effect of combined aerobic and resistance exercise training on vascular function in type 2 diabetes | Q43723172 | ||
Diabetes-related changes in cAMP response element-binding protein content enhance smooth muscle cell proliferation and migration. | Q43740242 | ||
Inhibition of phosphatidylinositol 3-kinase enhances mitogenic actions of insulin in endothelial cells | Q43798535 | ||
Prevention Conference VI: Diabetes and Cardiovascular Disease: Writing Group II: pathogenesis of atherosclerosis in diabetes | Q43982332 | ||
Obesity accelerates the progression of coronary atherosclerosis in young men. | Q44023041 | ||
Hyperglycaemia inhibits thymidine incorporation and cell growth via protein kinase C, mitogen-activated protein kinases and nitric oxide in human umbilical vein endothelium | Q44351396 | ||
Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomized trial | Q44396155 | ||
High glucose alters matrix metalloproteinase expression in two key vascular cells: potential impact on atherosclerosis in diabetes. | Q44474834 | ||
Increased transvascular low density lipoprotein transport in insulin dependent diabetes: a mechanistic model for development of atherosclerosis | Q44574970 | ||
Insulin Affects Vascular Smooth Muscle Cell Phenotype and Migration Via Distinct Signaling Pathways | Q44599804 | ||
Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity | Q44642265 | ||
Association of the metabolic syndrome with history of myocardial infarction and stroke in the Third National Health and Nutrition Examination Survey | Q44693873 | ||
Insulin enhances vascular cell adhesion molecule-1 expression in human cultured endothelial cells through a pro-atherogenic pathway mediated by p38 mitogen-activated protein-kinase | Q44755613 | ||
Effect of rosiglitazone on common carotid intima-media thickness progression in coronary artery disease patients without diabetes mellitus | Q44786820 | ||
P433 | issue | 4 | |
P921 | main subject | insulin resistance | Q1053470 |
atherosclerosis | Q12252367 | ||
P304 | page(s) | 455-463 | |
P577 | publication date | 2007-07-01 | |
P1433 | published in | Diabetes, Obesity and Metabolism | Q5270109 |
P1476 | title | Atherosclerosis in diabetes and insulin resistance | |
P478 | volume | 9 |
Q48099420 | Association of pulse pressure with left ventricular geometry and function in elderly nonhypertensive patients with diabetes: A 3D speckle tracking echocardiography study. |
Q35137148 | Cardiovascular disease in diabetes: where does glucose fit in? |
Q58007771 | Changes in arginine are inversely associated with type 2 diabetes: A case-cohort study in the PREDIMED trial |
Q37011769 | Clinical Update: Cardiovascular Disease in Diabetes Mellitus: Atherosclerotic Cardiovascular Disease and Heart Failure in Type 2 Diabetes Mellitus - Mechanisms, Management, and Clinical Considerations |
Q42522031 | Cod liver oil supplementation improves cardiovascular and metabolic abnormalities in streptozotocin diabetic rats |
Q26827620 | Diabetes and cardiovascular disease: changing the focus from glycemic control to improving long-term survival |
Q34830905 | Diabetes-related microvascular and macrovascular diseases in the physical therapy setting |
Q21245065 | Dietary carbohydrate restriction in type 2 diabetes mellitus and metabolic syndrome: time for a critical appraisal |
Q34983044 | Dietary epicatechin promotes survival of obese diabetic mice and Drosophila melanogaster |
Q35949722 | Efficacy of various antidiabetic agents as add-on treatments to metformin in type 2 diabetes mellitus: systematic review and meta-analysis. |
Q42153827 | Global gene expression profiling displays a network of dysregulated genes in non-atherosclerotic arterial tissue from patients with type 2 diabetes |
Q36935873 | Lifetime body mass index and later atherosclerosis risk in young adults: examining causal links using Mendelian randomization in the Cardiovascular Risk in Young Finns study |
Q34485920 | Loss of insulin signaling in vascular endothelial cells accelerates atherosclerosis in apolipoprotein E null mice |
Q37494520 | Pathogenesis and pathophysiology of accelerated atherosclerosis in the diabetic heart. |
Q42946155 | Protein tyrosine phosphatase PTPεM negatively regulates PDGF β-receptor signaling induced by high glucose and PDGF in vascular smooth muscle cells |
Q90164224 | Statin prescription among patients with type 2 diabetes in Botswana: findings and implications |
Search more.